Trial Investigating the Absorption, Metabolism and Excretion After a Single Subcutaneous Dose of [3H]-Semaglutide in Healthy Male Subjects
Clinical trial NCT02060266 · COMPLETED
Trial details
- NCT number
- NCT02060266
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-04
- Primary completion
- 2014-04-28
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.